Back to search

Artelo Biosciences Limited

10800659

active
ltd
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

Mereside, Alderley Park, Alderley Edge, SK10 4TG
Incorporated 02/06/2017

Previously known as

Trinity Research & Development Limited · until 08/01/2020

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 02/01/2026

Due 16/01/2027

On track

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Gregory Gorgas

director · Since 01/08/2017

DIRECTOR

AMERICAN · UNITED STATES · Age 63

Mr William Gerard O'Brien

secretary · Since 28/03/2018

Also on 2 other boards

Mr William Gerard O'Brien

director · Since 18/12/2019

DIRECTOR

BRITISH · ENGLAND · Age 56

Also on 2 other boards

Dr Andrew Stephen Yates

director · Since 04/03/2022

CSO

BRITISH · ENGLAND · Age 50

Gregory Gorgas

director · Since 01/08/2017

American · United States · Age 63

William Gerard O'Brien

secretary · Since 28/03/2018

William Gerard O'Brien

director · Since 18/12/2019

British · England · Age 56

Andrew Stephen Yates

director · Since 04/03/2022

British · England · Age 50

Former

Peter O'Brien

director · Resigned 15/11/2021

Randall Wade Schreckhise

director · Resigned 15/02/2022

Persons with Significant Control

Artelo Biosciences Inc

75–100% shares

505, Lomas Santa Fe, Solana Beach, 92075

Reg: C20171013-0837 · Nevada · Us Public Company

Notified 07/06/2017

Former PSCs

Trinity Reliant Ventures Limited

Ceased 07/06/2017

Change History

statusactive
2026-07-24

Active

typeltd
2026-07-24

Private Limited Company

address line1Mereside
2026-07-24

MERESIDE

post townAlderley Edge
2026-07-24

ALDERLEY EDGE

officer appointedO'BRIEN, William Gerard
2026-07-24
officer appointedGORGAS, Gregory
2026-07-24
officer appointedO'BRIEN, William Gerard
2026-07-24
officer appointedYATES, Andrew Stephen, Dr
2026-07-24

CompanyRankvs 4655+ SIC 72190 peers
41

Financial strength3th percentile among SIC peers · 1/25
Employees91th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.35× · 2/20
Longevity9 years trading (max 15) · 9/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity9/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

-£438k

Balance sheet strength

Cash

£115k

Cash in the bank

Net Current Assets

-£438k

Working capital

Current Assets

£231k

Current Liabilities

£669k

Debtors

£116k

7avg. employees

Balance Sheet

Assets less current liabilities-£438k
Signed by Mr W G O'Brien 17 August 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.35-£606k
20241.38+£148k
20231.81

Derived from filed accounts. Not audited figures.